DOLCEPOST SDN. BHD. – Trademark Portfolio
Entity Type: 03
DOLCEPOST SDN. BHD. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include ORALSPA, HYPER GEAR, ACTIVE GUARD, FUSION FOODS, and RAW FOOD LIFE. The owner is based in Subang Jaya, Selangor.
45, Block C, Lot 11082 Jalan Subang 2
Subang Light Industrial Park
Subang Jaya, Selangor 47500 , MY
Showing of trademarks Trademarks
Trademark Classifications
DOLCEPOST SDN. BHD.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does DOLCEPOST SDN. BHD. have?
DOLCEPOST SDN. BHD. has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.
What trademark classes does DOLCEPOST SDN. BHD. file in?
DOLCEPOST SDN. BHD. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 21 (Housewares). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are DOLCEPOST SDN. BHD.'s most well-known trademarks?
DOLCEPOST SDN. BHD.'s registered trademark portfolio includes well-known marks such as ORALSPA, HYPER GEAR, ACTIVE GUARD, FUSION FOODS, and RAW FOOD LIFE. These are among 5 currently registered trademarks in the portfolio.
What is DOLCEPOST SDN. BHD.'s trademark registration success rate?
DOLCEPOST SDN. BHD. has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.